NPS Pharmaceuticals Inc (NPSP)

45.97
0.01 0.02
Prev Close 45.96
Open 45.96
Day Low/High 45.95 / 45.99
52 Wk Low/High 22.11 / 46.01
Volume 9.49M
Avg Volume 4.75M
Exchange
Shares Outstanding 108.58M
Market Cap 4.99B
EPS -0.08
Div & Yield N.A. (N.A)
2014 FDA Drug Approval Calendar

2014 FDA Drug Approval Calendar

A list of drugs under FDA review and scheduled FDA advisory panel meetings.

Why NPS Pharmaceuticals (NPSP) Stock Is Down This Afternoon

Why NPS Pharmaceuticals (NPSP) Stock Is Down This Afternoon

Shares of NPS Pharmaceuticals (NPSP) are lower by -7.54% after the company cut its 2014 forecast and now sees 2014 sales of $100 million to $110 million, down from the previous forecast of $110 million to $120 million.

NPS Pharma Blames Winter, Drug Stops for Weak First Quarter, Reduced Guidance

NPS Pharma Blames Winter, Drug Stops for Weak First Quarter, Reduced Guidance

Gattex sales in the March quarter missed consensus expectations and 2014 sales guidance was reduced by $10 million.

NPS Pharma Reports First-Quarter 2014 Financial Results

NPS Pharma Reports First-Quarter 2014 Financial Results

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today reported its results for the quarter ...

NPS Pharma Among 100 Best Places To Work In New Jersey For Third Consecutive Year

NPS Pharma Among 100 Best Places To Work In New Jersey For Third Consecutive Year

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, has been named one of the Best Places to Work in...

NPS Pharmaceuticals (NPSP) Shares Cross Above 200 DMA

NPS Pharmaceuticals (NPSP) Shares Cross Above 200 DMA

In trading on Monday, shares of NPS Pharmaceuticals Inc. crossed above their 200 day moving average of $28.65, changing hands as high as $29.01 per share.

NPS Pharmaceuticals To Report First Quarter 2014 Financial Results

NPS Pharmaceuticals To Report First Quarter 2014 Financial Results

NPS Pharmaceuticals, Inc. (Nasdaq:NPSP) announced today that it will report its first quarter 2014 financial results on Thursday, May 8, 2014 at approximately 8:00 a.

NPS Pharmaceuticals To Present At Bank Of America Merrill Lynch Health Care Conference

NPS Pharmaceuticals To Present At Bank Of America Merrill Lynch Health Care Conference

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) will present at the Bank of America Merrill Lynch Health Care Conference in Las Vegas on Tuesday, May 13, 2014 at 8:40 a.

NPS Pharmaceuticals To Present At Needham Healthcare Conference

NPS Pharmaceuticals To Present At Needham Healthcare Conference

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) will present at the 13 th Annual Needham Healthcare Conference in New York on Tuesday, April 8, 2014 at 8:00 a.

NPS Pharmaceuticals (NPSP) In A Perilous Reversal

NPS Pharmaceuticals (NPSP) In A Perilous Reversal

Trade-Ideas LLC identified NPS Pharmaceuticals (NPSP) as a "perilous reversal" (up big yesterday but down big today) candidate

Trade-Ideas: NPS Pharmaceuticals (NPSP) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas: NPS Pharmaceuticals (NPSP) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas LLC identified NPS Pharmaceuticals (NPSP) as a "dead cat bounce" (down big yesterday but up big today) candidate

NPS Pharmaceuticals Expands Executive Leadership Team To Support Its U.S. And International Growth And Global Orphan-Drug Leadership

NPS Pharmaceuticals Expands Executive Leadership Team To Support Its U.S. And International Growth And Global Orphan-Drug Leadership

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced the appointment and...

NPS Pharmaceuticals Joins Participants From Around The World In Observing Rare Disease Day

NPS Pharmaceuticals Joins Participants From Around The World In Observing Rare Disease Day

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today joins patient organizations, healthcare...

NPS Pharmaceuticals To Present At Barclays Global Healthcare Conference

NPS Pharmaceuticals To Present At Barclays Global Healthcare Conference

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) will present at the Barclays Global Healthcare Conference in Miami, Florida on Tuesday, March 11, 2014 at 9:00 a.

NPS Pharmaceuticals Larger Than S&P 500 Component Ryder System

NPS Pharmaceuticals Larger Than S&P 500 Component Ryder System

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component NPS Pharmaceuticals Inc. was identified as having a larger market cap than the smaller end of the S&P 500, for example Ryder System, Inc.

Trade-Ideas: NPS Pharmaceuticals (NPSP) Is Today's Post-Market Leader Stock

Trade-Ideas: NPS Pharmaceuticals (NPSP) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified NPS Pharmaceuticals (NPSP) as a post-market leader candidate

NPS Pharmaceuticals Reports Fourth Quarter And Full-Year 2013 Financial Results And Financial Outlook For 2014

NPS Pharmaceuticals Reports Fourth Quarter And Full-Year 2013 Financial Results And Financial Outlook For 2014

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today reported financial results for...

Trade-Ideas: NPS Pharmaceuticals (NPSP) Is Today's Post-Market Leader Stock

Trade-Ideas: NPS Pharmaceuticals (NPSP) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified NPS Pharmaceuticals (NPSP) as a post-market leader candidate

NPS Pharmaceuticals To Report 2013 Financial Results

NPS Pharmaceuticals To Report 2013 Financial Results

NPS Pharmaceuticals, Inc. (Nasdaq:NPSP) announced today that it will report its 2013 financial results on Tuesday, February 18, 2014 at approximately 4:30 p.

NPS Pharmaceuticals Inc Stock Upgraded (NPSP)

NPS Pharmaceuticals Inc Stock Upgraded (NPSP)

NPS Pharmaceuticals (Nasdaq:NPSP) has been upgraded by TheStreet Ratings from a sell to hold.

Ratings Changes Today

Upgrades: CZFC, NPSP, SCCO, STR, TWI Downgrades: BRLI Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Commit To Buy NPS Pharmaceuticals At $23, Earn 13.5% Using Options

Commit To Buy NPS Pharmaceuticals At $23, Earn 13.5% Using Options

Investors considering a purchase of NPS Pharmaceuticals Inc. shares, but tentative about paying the going market price of $35.63/share, might benefit from considering selling puts among the alternative strategies at their disposal.

It's Lunchtime at the J.P. Morgan Healthcare Confab. Here's What I Learned So Far

It's Lunchtime at the J.P. Morgan Healthcare Confab. Here's What I Learned So Far

Here are some random thoughts and observations from what I saw and heard this morning. Totally off the cuff stuff on Celgene, InterMune, Alnylam, NPS Pharma and Seattle Genetics.

NPS Pharmaceuticals (NPSP) Marked As A Barbarian At The Gate

NPS Pharmaceuticals (NPSP) Marked As A Barbarian At The Gate

Trade-Ideas LLC identified NPS Pharmaceuticals (NPSP) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

NPS Pharmaceuticals Reports Preliminary 2013 Results And 2014 Financial Outlook

NPS Pharmaceuticals Reports Preliminary 2013 Results And 2014 Financial Outlook

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced preliminary financial...

NPS Pharmaceuticals Announces FDA Acceptance Of Biologics License Application For Natpara® For The Treatment Of Hypoparathyroidism

NPS Pharmaceuticals Announces FDA Acceptance Of Biologics License Application For Natpara® For The Treatment Of Hypoparathyroidism

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that the U.

NPS Pharmaceuticals To Present At J.P. Morgan Healthcare Conference

NPS Pharmaceuticals To Present At J.P. Morgan Healthcare Conference

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) will present at the 32 nd Annual J.

Analysts Issue Bullish Biotech Outlooks for '14, Except Goldman, Which Is Negative

Analysts Issue Bullish Biotech Outlooks for '14, Except Goldman, Which Is Negative

The favorite stocks of the sell-side for 2014 include Gilead Sciences, Vertex, NPS Pharma, Medivation and Regeneron Pharma.

NPS Pharmaceuticals Receives Orphan Drug Designation For Natpara® In Europe

NPS Pharmaceuticals Receives Orphan Drug Designation For Natpara® In Europe

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European Commission has...

NPS Pharmaceuticals Initiates Global Registration Study Of Teduglutide In Pediatric Patients With Short Bowel Syndrome

NPS Pharmaceuticals Initiates Global Registration Study Of Teduglutide In Pediatric Patients With Short Bowel Syndrome

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that the company has...